Melanoma vs. Non-Melanoma Skin Cancer: Diagnosis, Symptoms and Differences

Melanoma vs. Non-Melanoma Skin Cancer: Diagnosis, Symptoms and Differences. Learn the differences between melanoma and non-melanoma skin cancers, including warning signs, diagnosis, biopsy, dermoscopy, and when to evaluate suspicious spots.

Melanoma and non-melanoma skin cancers are different diseases. Melanoma develops from melanocytes, the pigment-producing cells of the skin, and is less common but generally more likely to spread. Non-melanoma skin cancers—especially basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)—are much more common and are usually highly treatable when found early. A dermatologist may examine suspicious lesions with a dermoscope, but a skin biopsy and pathology examination are generally required to confirm a skin cancer diagnosis.

Melanoma vs. non-melanoma comparison table

	Melanoma	Basal Cell Carcinoma (BCC)	Squamous Cell Carcinoma (SCC)
Cell of origin	Melanocytes	Basal cells	Squamous cells
Relative frequency	Less common	Very common	Very common
Typical appearance	New/changing or unusual mole/spot	Pearly, shiny bump or non-healing sore	Scaly/red patch, sore or growth
Risk of spreading	Higher	Usually very low	Low, but can spread
Diagnosis	Skin exam + biopsy	Skin exam + biopsy	Skin exam + biopsy
Importance of early detection	Very high	High	High

What Does Melanoma Look Like?

Use the ABCDE rule:

A — Asymmetry
B — Border irregularity
C — Color variation
D — Diameter
E — Evolving

What Does Non-Melanoma Skin Cancer Look Like?

This is equally important because BCC and SCC don’t necessarily look like melanoma.

Examples include:

non-healing sore
shiny or pearly bump
rough/scaly patch
crusting or bleeding lesion
wart-like growth
persistent red patch
scar-like area

The American Cancer Society specifically notes that basal and squamous cell cancers can appear in many forms and may not resemble a mole at all.

How Skin Cancer Is Diagnosed

Step 1 — Skin self-examination

Patient notices a:

new spot
changing mole
non-healing sore
bleeding lesion
itching lesion
unusual “ugly duckling” spot.

Step 2 — Dermatologist examination

The dermatologist examines the lesion and the patient’s skin.

Step 3 — Dermoscopy

A dermoscope allows magnified examination of structures that cannot easily be seen with the naked eye.

This is one place where your existing recommendation is strong. Current melanoma guidelines support dermoscopy by experienced clinicians because it improves diagnostic accuracy.

Step 4 — Biopsy

The American Academy of Dermatology states that biopsy is how skin cancer is definitively diagnosed, with the tissue then examined microscopically by a pathologist/dermatopathologist.

ESMO similarly recommends diagnosis based on tissue obtained through complete excision when feasible.

That should be the hierarchy presented to PBC readers.

Can Gene-Expression Testing Help Evaluate Suspicious Moles?

Non-invasive molecular tests have been studied as tools that may help dermatologists evaluate selected suspicious pigmented lesions. These tests should be viewed as adjunctive diagnostic tools rather than replacements for dermatologist evaluation and biopsy when melanoma is suspected.

What Happens After a Melanoma Biopsy?

melanoma type
Breslow thickness
ulceration
margins
mitotic activity
other pathological characteristics

Breslow thickness is especially important because tumor depth helps determine subsequent staging and treatment decisions. Current guidelines specify detailed histopathologic reporting after melanoma diagnosis.

FAQ

Is melanoma always a mole?

No. Melanoma can appear as a new spot or growth and can occur in locations patients may not associate with sun exposure.

Can melanoma be smaller than 6 mm?

Yes. Although diameter is part of ABCDE screening, melanomas can be smaller than 6 mm.

Can a dermatologist tell if a mole is cancerous just by looking at it?

Clinical examination and dermoscopy can identify suspicious lesions, but biopsy provides definitive diagnosis.

What is the difference between melanoma and basal cell carcinoma?

Basal cell carcinoma (BCC) and melanoma are both types of skin cancer caused by ultraviolet (UV) damage, but they behave very differently. BCC is the most common and slowest-growing form, rarely spreading to other parts of the body. Melanoma is less common but much more aggressive and dangerous, as it can spread quickly if not found early. [1, 2, 3, 4, 5, 6]

What is the difference between melanoma and squamous cell carcinoma?

Squamous cell carcinoma and melanoma are both types of skin cancer, but they start in different cells, look different, and carry different risks. Squamous cell carcinoma starts in flat upper skin cells, while melanoma starts in pigment-making cells. Melanoma is much more aggressive and dangerous. [1, 2, 3]

Does every suspicious mole need to be biopsied?

Not every mole that looks slightly unusual or atypical requires an immediate skin biopsy. A doctor or dermatologist evaluates factors like personal history, stability, and specific visual traits before deciding whether to perform a mole removed for biopsy or to use a watch-and-wait approach. [1, 2, 3]

PeopleBeatingCancer Evidence Rating — Skin Cancer Diagnosis

Diagnostic approach	Evidence	PBC rating
Dermatologist skin examination	Strong	★★★★★
Dermoscopy by experienced clinician	Strong	★★★★★
Biopsy + histopathology	Diagnostic standard	★★★★★
ABCDE/self-examination	Strong for identifying suspicious lesions	★★★★☆
Total-body photography in selected high-risk patients	Moderate–strong	★★★★☆
Non-invasive gene-expression testing	Emerging/adjunctive	★★★☆☆
Hereditary genetic testing for everyone	Not routinely indicated	★★☆☆☆

PBC Evidence Rating: Ratings reflect the strength and consistency of available clinical evidence, not a guarantee that an approach is appropriate for every patient. Diagnostic decisions should be made with a qualified dermatologist or oncology team.

Once melanoma has been diagnosed, treatment depends heavily on stage. For advanced melanoma, immunotherapies such as Keytruda (pembrolizumab) may become part of treatment.

Patients interested in lowering future risk may also want to read PBC’s guide to preventing skin cancer.

I am a cancer survivor and cancer coach. I have watched early-stage breast and prostate cancer survivors benefit from similar gene tests. Patients need all the information they can get. Gene tests that indicate the type and stage of skin cancer is another important piece of the puzzle.

The third and final step is to add evidence-based, non-toxic nutrition, supplementation, and lifestyle therapies into your day in order to reduce your risks of melanoma.

Have you been diagnosed with skin cancer- melanoma or non-melanoma? Scroll down the page, post a question or comment and I will reply to you ASAP.

Thank you,

David Emerson

Cancer Survivor
Cancer Coach
Director PeopleBeatingCancer

To Learn More:

Noninvasive 2-Gene Test Helps Distinguish Melanoma From Nonmelanoma

“A new 2-gene pigmented lesion test that classifies skin lesions as melanoma or nonmelanoma could help with diagnostic challenges physicians frequently face with the visual image and pattern recognition approach…

Accurate clinical and histopathological analysis of pigmented skin lesions is difficult even for experts. Accurate, noninvasive diagnostic techniques could help in skin cancer diagnoses…

This 2-gene approach with LINC00518 and/or PRAME detection distinguished melanoma from nonmelanoma with 91% sensitivity and 69% specificity…”

SHOULD I GET GENETIC TESTING FOR MELANOMA?

“Genetic testing may be recommended when you have one of these risks

In the United States, a dermatologist may consider genetic counseling and possibly genetic testing for melanoma if you have had one (or more) of the following:

3 or more melanomas that have grown deep into your skin (or spread), especially if one melanoma was diagnosed before your 45th birthday
3 or more blood relatives on one side of your family who have had melanoma or cancer of the pancreas
2 or more unusual-looking moles called Spitz nevi
1 or more Spitz nevi and a close blood relative has (or had) mesothelioma (a type of cancer), meningioma (a type of brain tumor), or melanoma of the eye¹

Positive genetic test for melanoma can provide important information

A genetic test for melanoma can tell you about more than your melanoma risk. People who carry a mutation on a gene known as CDKN2A have a higher risk of developing melanoma, cancer of the pancreas, or a tumor in the central nervous system.

A mutation on the gene called BAP1 means a higher risk of getting melanoma, melanoma of the eye, or cancers like mesothelioma and kidney cancer.

A genetic test cannot tell you whether will develop one of these cancers.

But knowing these risks can be helpful. It can help people get needed cancer screenings.

A positive test for melanoma can also help your dermatologist monitor you for signs of skin cancer. Patients with a high risk may need more frequent skin cancer screenings. Total body photography can show changes to your moles, which can help find a melanoma in its earliest stage.

A positive test also has some drawbacks. It causes some people to feel anxious and worried. Some people worry that an insurance company may discriminate against them.

Negative test can give you a false sense of security

If the test shows that you don’t have a gene mutation for melanoma, that’s great news. But it doesn’t mean that you cannot get melanoma. More people are diagnosed with melanoma than ever before. Most of them, 90%, don’t have a gene mutation that increases their risk.

Dermatologists caution that everyone needs to protect their skin from the sun. You still need to check your skin for signs of skin cancer. And you should keep all follow-up appointments with your dermatologist.

Our Mission